Glenmark Pharmaceuticals has informed that it has attached media release on 15th June 2021, titled ‘Glenmark launches Tiogiva®, becoming one of the first companies in the UK to launch a bioequivalent version of Tiotropium Bromide dry powder inhaler’ which is self?explanatory.
The above information is a part of company’s filings submitted to BSE.